Edwards Lifesciences to sell critical care unit to Becton Dickinson for $4.2 billion

Edwards Lifesciences has agreed to sell its critical care products unit to Becton Dickinson in an all-cash deal valued at $4.2 billion. The unit develops and sells advanced blood and heart monitoring systems used in surgical and intensive care settings.

“Edwards Lifesciences on Monday said it has agreed to sell its critical care products unit to Becton Dickinson in an all-cash deal valued at $4.2 billion to sharpen focus on its heart devices business.”reuters.com

• 1 source
• reuters.comEdwards to sell critical care products unit to Becton Dickinson for $4.2 blnPratik JainJun 3, 2024

Summarized from public sources; check the original articles before acting on it.